ArticleCancer chemotherapy and pharmacology2016

Accounting for dropout in xenografted tumour efficacy studies: integrated endpoint analysis, reduced bias and better use of animals.

Emma C Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.